Related references
Note: Only part of the references are listed.The Global Ascendency of OXA-48-Type Carbapenemases
Johann D. D. Pitout et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
Epidemiology of beta-Lactamase-Producing Pathogens
Karen Bush et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
Critical analysis of antibacterial agents in clinical development
Ursula Theuretzbacher et al.
NATURE REVIEWS MICROBIOLOGY (2020)
NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings
Wenjing Wu et al.
CLINICAL MICROBIOLOGY REVIEWS (2019)
Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018
Alma Brolund et al.
EUROSURVEILLANCE (2019)
Interplay between β-lactamases and new β-lactamase inhibitors
Karen Bush et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Variations in the Occurrence of Resistance Phenotypes and Carbapenemase Genes Among Enterobacteriaceae Isolates in 20 Years of the SENTRY Antimicrobial Surveillance Program
Mariana Castanheira et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Management of carbapenem-resistant Enterobacteriaceae infections
E. Durante-Mangoni et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study
Andrew Stewardson et al.
LANCET INFECTIOUS DISEASES (2019)
Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria
Patrice Nordmann et al.
CLINICAL INFECTIOUS DISEASES (2019)
Evaluation of temocillin and meropenem MICs as diagnostic markers for OXA-48-like carbapenemases
Katie L. Hopkins et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae
Jesus Rodriguez-Bano et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016)
Michael A. Pfaller et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Review and mapping of carbapenem-resistant Enterobacteriaceae in Africa: Using diverse data to inform surveillance gaps
Elizabeth A. Mitgang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme
Michael A. Pfaller et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Carbapenem Nonsusceptible Klebsiella pneumoniae in Taiwan: Dissemination and Increasing Resistance of Carbapenemase Producers During 2012-2015
Sheng-Kang Chiu et al.
SCIENTIFIC REPORTS (2018)
In Vitro Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam against OXA-48-Carrying Enterobacteriaceae Isolated as Part of the International Network for Optimal Resistance Monitoring (INFORM) Global Surveillance Program from 2012 to 2015
Krystyna M. Kazmierczak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012-2016)
Qi Wang et al.
CLINICAL INFECTIOUS DISEASES (2018)
Carbapenemase-Producing Organisms: A Global Scourge
Robert A. Bonomo et al.
CLINICAL INFECTIOUS DISEASES (2018)
A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae
Karlijn van Loon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Acquisition of Carbapenem Resistance by Plasmid-Encoded-AmpC-Expressing Escherichia coli
Ria van Boxtel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia
Li-Yang Hsu et al.
CLINICAL MICROBIOLOGY REVIEWS (2017)
The epidemiology of carbapenemases in Latin America and the Caribbean
Kevin Escandon-Vargas et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2017)
Distribution of ESBLs, AmpC β-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008-14: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)
Shio-Shin Jean et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
The global epidemiology of carbapenemase-producing Enterobacteriaceae
David van Duin et al.
VIRULENCE (2017)
Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in Belgium from September to November 2015
T. D. Huang et al.
EUROSURVEILLANCE (2017)
Trends in carbapenemase-producing Enterobacteriaceae, France, 2012 to 2014
L. Dortet et al.
EUROSURVEILLANCE (2017)
Carbapenem-Resistant Enterobacteriaceae: A Strategic Roadmap for Infection Control
N. Deborah Friedman et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2017)
OXA-48-like carbapenemases in the UK: an analysis of isolates and cases from 2007 to 2014
Jacqueline Findlay et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
In Vitro Activity of Imipenem against Carbapenemase-Positive Enterobacteriaceae Isolates Collected by the SMART Global Surveillance Program from 2008 to 2014
James A. Karlowsky et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2017)
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace
Latania K. Logan et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts
H Grundmann et al.
Eurosurveillance (2017)
Molecular and microbiological report of a hospital outbreak of NDM-1-carrying Enterobacteriaceae in Mexico
Paola Bocanegra-Ibarias et al.
PLOS ONE (2017)
Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance
Shiri Navon-Venezia et al.
FEMS MICROBIOLOGY REVIEWS (2017)
Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations
Herve Dupont et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Global Dissemination of blaKPC into Bacterial Species beyond Klebsiella pneumoniae and In Vitro Susceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam
Krystyna M. Kazmierczak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Carbapenemase-producing Escherichia coli is becoming more prevalent in Spain mainly because of the polyclonal dissemination of OXA-48
Adriana Ortega et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Combinations of mutations in envZ, ftsI, mrdA, acrB and acrR can cause high-level carbapenem resistance in Escherichia coli
Marlen Adler et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Outbreak Caused by Enterobacteriaceae Harboring NDM-1 Metallo-β-Lactamase Carried in an IncFII Plasmid in a Tertiary Care Hospital in Mexico City
Pedro Torres-Gonzalez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Trends in Susceptibility of Escherichia coli from Intra-Abdominal Infections to Ertapenem and Comparators in the United States According to Data from the SMART Program, 2009 to 2013
Sibylle H. Lob et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Xian-Zhi Li et al.
CLINICAL MICROBIOLOGY REVIEWS (2015)
Notes from the Field: Carbapenem-resistant Enterobacteriaceae Producing OXA-48-like Carbapenemases - United States, 2010-2015 (vol 64, pg 1315, 2015)
Meghan Lyman et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2015)
The spread of carbapenemase-producing bacteria in Africa: a systematic review
Rendani I. Manenzhe et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide
P. Nordmann et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013
C Glasner et al.
Eurosurveillance (2013)
Stormy waters ahead: global emergence of carbapenemases
Gopi Patel et al.
FRONTIERS IN MICROBIOLOGY (2013)
Carbapenemases: Partners in crime
Karen Bush
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2013)
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
R. Canton et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
OXA-48-like carbapenemases: the phantom menace
Laurent Poirel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Global Spread of Carbapenemase-producing Enterobacteriaceae
Patrice Nordmann et al.
EMERGING INFECTIOUS DISEASES (2011)
Updated Functional Classification of beta-Lactamases
Karen Bush et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Role of β-lactamases and porins in resistance to ertapenem and other β-lactams in Klebsiella pneumoniae
GA Jacoby et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Share Paper
